Advertisement

Reactions Weekly

, Volume 1747, Issue 1, pp 18–18 | Cite as

Alemtuzumab

Papillary thyroid cancer: case report
Case report
  • 24 Downloads

Reference

  1. Kim H, et al. Efficacy and safety of alemtuzumab in Korean multiple sclerosis patients. Multiple Sclerosis and Related Disorders 30: 247-251, May 2019. Available from: URL: http://doi.org/10.1016/j.msard.2019.03.001 - SouthKoreaCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations